A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression

Clinical trial NCT02497287 · COMPLETED

Trial details

NCT number: NCT02497287
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Treatment-resistant Depression

Start date: 2015-09-30
Primary completion: 2017-10-28
Enrollment: 802

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.